CoChat

Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol

Open access

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

Abstract

We previously showed that macrophages from macrophage-specific ATP-binding cassette transporter A1 (ABCA1) knockout (Abca1(-M/-M)) mice had an enhanced proinflammatory response to the Toll-like receptor (TLR) 4 agonist, lipopolysaccharide (LPS), compared with wild-type (WT) mice. In the present study, we demonstrate a direct association between free cholesterol (FC), lipid raft content, and hyper-responsiveness of macrophages to LPS in WT mice. Abca1(-M/-M) macrophages were also hyper-responsive to specific agonists to TLR2, TLR7, and TLR9, but not TLR3, compared with WT macrophages. We hypothesized that ABCA1 regulates macrophage responsiveness to TLR agonists by modulation of lipid raft cholesterol and TLR mobilization to lipid rafts. We demonstrated that Abca1(-M/-M) vs. WT macrophages contained 23% more FC in isolated lipid rafts. Further, mass spectrometric analysis suggested raft phospholipid composition was unchanged. Although cell surface expression of TLR4 was similar between Abca1(-M/-M) and WT macrophages, significantly more TLR4 was distributed in membrane lipid rafts in Abca1(-M/-M) macrophages. Abca1(-M/-M) macrophages also exhibited increased trafficking of the predominantly intracellular TLR9 into lipid rafts in response to TLR9-specific agonist (CpG). Collectively, our data suggest that macrophage ABCA1 dampens inflammation by reducing MyD88-dependent TLRs trafficking to lipid rafts by selective reduction of FC content in lipid rafts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1194/jlr.m006486

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Manipulation of cellular FC content alters proinfl ammatory status and cell surface lipid raft, but not TLR4, content. A: WT BMDMs were incubated at 37°C with M 𝛃 CD for 0.5 h or with M 𝛃 CD-chol for 1 h before FC measurement by GLC. B: WT BMDMs were incubated with Kdo2-lipid A for 6 h after incubation with M 𝛃 CD or M 𝛃 CD-chol, and cytokine expression was measured by ELISA. Cytokine concentration was plotted against FC content of macrophages. The line of best fi t for IL-6 ( r 2 = 0.92) and IL-12p40 ( r 2 = 0.75) is shown. C-E: WT-elicited PMs were treated with M 𝛃 CD or M 𝛃 CD-chol before stained with fPEG-chol (C), Alexa fl uor CT-B (D), or APC-TLR4/MD2 (MTS510) (E). Cells were analyzed using fl ow cytometry. Histogram of individual samples is shown in the left panel and mean fl uorescence intensity is shown in the right panel. Values with unlike letters are signifi cantly different ( P < 0.05). Results represent mean ± SEM of 2 independent experiments; n = 4-5 dishes of cells/group. Chol: M 𝛃 CD-cholesterol.
Fig. 1 Manipulation of cellular FC content alters proinfl ammatory status and cell surface lipid raft, but not TLR4, content. A: WT BMDMs were incubated at 37°C with M 𝛃 CD for 0.5 h or with M 𝛃 CD-chol for 1 h before FC measurement by GLC. B: WT BMDMs were incubated with Kdo2-lipid A for 6 h after incubation with M 𝛃 CD or M 𝛃 CD-chol, and cytokine expression was measured by ELISA. Cytokine concentration was plotted against FC content of macrophages. The line of best fi t for IL-6 ( r 2 = 0.92) and IL-12p40 ( r 2 = 0.75) is shown. C-E: WT-elicited PMs were treated with M 𝛃 CD or M 𝛃 CD-chol before stained with fPEG-chol (C), Alexa fl uor CT-B (D), or APC-TLR4/MD2 (MTS510) (E). Cells were analyzed using fl ow cytometry. Histogram of individual samples is shown in the left panel and mean fl uorescence intensity is shown in the right panel. Values with unlike letters are signifi cantly different ( P < 0.05). Results represent mean ± SEM of 2 independent experiments; n = 4-5 dishes of cells/group. Chol: M 𝛃 CD-cholesterol.CC-BY · From the PDF
Fig. 2 Abca1 -M/-M macrophages are hypersensitive to TLR2, 7, and 9, but not to TLR3 stimulation. A-C: Elicited PMs were treated with Pam 3 SCK 4 (TLR2), Loxoribine (TLR7), or TLR9 for 0-12 h. The secretion of infl ammatory factors was measured by ELISA. D, E: PMs were treated with poly (I:C) (TLR3) for 0-12 h. Cytokine or chemokine secretion was measured by ELISA. Results represent mean ± SEM of at least two independent experiments; n = 3 dishes of cells/group. * P <0.05, compared with WT. +/+ : WT; -M/-M: Abca1 -M/-M .
Fig. 2 Abca1 -M/-M macrophages are hypersensitive to TLR2, 7, and 9, but not to TLR3 stimulation. A-C: Elicited PMs were treated with Pam 3 SCK 4 (TLR2), Loxoribine (TLR7), or TLR9 for 0-12 h. The secretion of infl ammatory factors was measured by ELISA. D, E: PMs were treated with poly (I:C) (TLR3) for 0-12 h. Cytokine or chemokine secretion was measured by ELISA. Results represent mean ± SEM of at least two independent experiments; n = 3 dishes of cells/group. * P <0.05, compared with WT. +/+ : WT; -M/-M: Abca1 -M/-M .CC-BY · From the PDF
Fig. 3 ABCA1 defi ciency in macrophages resulted in increased membrane lipid raft content. Elicited PMs were incubated with or without M 𝛃 CD for 0.5 h or M 𝛃 CD-chol (80 µg/ml) for 1 h before staining with fPEG-chol. Cell fl uorescence was analyzed using fl ow cytometry. A-C : Histograms show macrophage fPEG-chol staining in the absence (A) or presence (B) of M 𝛃 CD or presence of M 𝛃 CD-chol (C), respectively. D: Data from panels A-C are presented as mean ± SEM. Statistical signifi cant differences between groups are indicated (*, P < 0.05; **, P < 0.01). Results are representative of two independent experiments with at least three mice per group. +/+ : WT; -M/-M: Abca1 -M/-M .
Fig. 3 ABCA1 defi ciency in macrophages resulted in increased membrane lipid raft content. Elicited PMs were incubated with or without M 𝛃 CD for 0.5 h or M 𝛃 CD-chol (80 µg/ml) for 1 h before staining with fPEG-chol. Cell fl uorescence was analyzed using fl ow cytometry. A-C : Histograms show macrophage fPEG-chol staining in the absence (A) or presence (B) of M 𝛃 CD or presence of M 𝛃 CD-chol (C), respectively. D: Data from panels A-C are presented as mean ± SEM. Statistical signifi cant differences between groups are indicated (*, P < 0.05; **, P < 0.01). Results are representative of two independent experiments with at least three mice per group. +/+ : WT; -M/-M: Abca1 -M/-M .CC-BY · From the PDF
Image 4
CC-BY · From the PDF
Fig. 5 Increased TLR4 in lipid rafts of Abca1 -M/-M macrophages. A and B: Lipid raft and nonraft membrane regions were isolated using a nondetergent method and analyzed for TLR4, clathrin (non-raft marker), and CD14 (raft marker) distribution by Western blotting. C: BMDMs were treated with 100 ng/ml LPS for 1 h and then lipid raft (fractions 1-8) and nonraft (fractions 10-13) fractions were pooled, and the distribution of the indicated proteins was analyzed by Western blotting. Results are representative of two independent experiments. D: TLR4 content of macrophage lipid rafts was calculated as a percentage of total membrane TLR4 (lipid rafts + nonrafts). Data are presented as mean ± range (n = 2). Statistically signifi cant differences between genotypes are indicated (* P < 0.05). +/+ : WT, -M/-M: Abca1 - M/-M .
Fig. 5 Increased TLR4 in lipid rafts of Abca1 -M/-M macrophages. A and B: Lipid raft and nonraft membrane regions were isolated using a nondetergent method and analyzed for TLR4, clathrin (non-raft marker), and CD14 (raft marker) distribution by Western blotting. C: BMDMs were treated with 100 ng/ml LPS for 1 h and then lipid raft (fractions 1-8) and nonraft (fractions 10-13) fractions were pooled, and the distribution of the indicated proteins was analyzed by Western blotting. Results are representative of two independent experiments. D: TLR4 content of macrophage lipid rafts was calculated as a percentage of total membrane TLR4 (lipid rafts + nonrafts). Data are presented as mean ± range (n = 2). Statistically signifi cant differences between genotypes are indicated (* P < 0.05). +/+ : WT, -M/-M: Abca1 - M/-M .CC-BY · From the PDF
Fig. 6 NF𝛋 B pathway and lipid rafts are involved with enhanced TLR9 signaling in Abca1 -M/-M macrophages. A: BMDMs were incubated with 1 𝛍 M CpG for 0-3 h. Cell lysates were harvested and the proteins were analyzed by immunoblotting with the indicated antibodies. I 𝛋 B 𝛂 was quantifi ed and normalized to 𝛃 -actin. The degradation of I 𝛋 B 𝛂 induced by CpG stimulation is presented as fraction of basal protein level in control WT cells. B: BMDMs were fractioned into raft and nonraft fractions using a simplifi ed nondetergent method. The protein distribution in each fraction was analyzed by Western blotting using the indicated antibodies. C: BMDMs were treated with 1 𝛍 M CpG for 1 h and then lipid rafts (fractions 1-8) and nonrafts (fractions 10-13) were pooled, and the distribution of the indicated proteins was analyzed by Western blotting. D: Lipid raft and nonraft fractions isolated as described in panel C were pooled and immunoprecipitated with anti-TLR9 polyclonal antibody, followed by immunoblotting with anti-TLR9 polyclonal antibody. Results are representative of two independent experiments. E: Lipid raft TLR9 content in macrophages was calculated as a percentage of total TLR9 (lipid rafts + nonrafts). Data are presented as mean ± SEM; n = 3. Statistically signifi cant differences between groups are indicated (* P < 0.05). +/+ : WT, -M/-M: Abca1 -M/-M .
Fig. 6 NF𝛋 B pathway and lipid rafts are involved with enhanced TLR9 signaling in Abca1 -M/-M macrophages. A: BMDMs were incubated with 1 𝛍 M CpG for 0-3 h. Cell lysates were harvested and the proteins were analyzed by immunoblotting with the indicated antibodies. I 𝛋 B 𝛂 was quantifi ed and normalized to 𝛃 -actin. The degradation of I 𝛋 B 𝛂 induced by CpG stimulation is presented as fraction of basal protein level in control WT cells. B: BMDMs were fractioned into raft and nonraft fractions using a simplifi ed nondetergent method. The protein distribution in each fraction was analyzed by Western blotting using the indicated antibodies. C: BMDMs were treated with 1 𝛍 M CpG for 1 h and then lipid rafts (fractions 1-8) and nonrafts (fractions 10-13) were pooled, and the distribution of the indicated proteins was analyzed by Western blotting. D: Lipid raft and nonraft fractions isolated as described in panel C were pooled and immunoprecipitated with anti-TLR9 polyclonal antibody, followed by immunoblotting with anti-TLR9 polyclonal antibody. Results are representative of two independent experiments. E: Lipid raft TLR9 content in macrophages was calculated as a percentage of total TLR9 (lipid rafts + nonrafts). Data are presented as mean ± SEM; n = 3. Statistically signifi cant differences between groups are indicated (* P < 0.05). +/+ : WT, -M/-M: Abca1 -M/-M .CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 344

Metadata

Authors
Zhu, X., Owen, J. S., Wilson, M. D., Li, H., Griffiths, G. L., Thomas, M. J., Hiltbold, E. M., Fessler, M. B., & Parks, J. S.
Affiliations
  • Wake Forest University Health Sciences (US)
  • National Institutes of Health (US)
  • National Institute of Environmental Health Sciences (US)
Corresponding author
Parks, John S.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2010-11
Volume
51
Issue
11
Pages
3196-3206
ISSN
0022-2275 (ISSN-L)
OpenAlex
W2143004078
Cited by
331
References
49
Citations by year
2026: 14 · 2025: 17 · 2024: 16 · 2023: 17 · 2022: 26 · 2021: 22 · 2020: 14 · 2019: 21 · 2018: 24 · 2017: 21 · 2016: 28 · 2015: 34 · 2014: 26 · 2013: 26 · 2012: 14
FWCI
7.01
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Auburn University Scholarly Repository
Funders
  • American Heart Association
  • National Institutes of Health (ES102005)
  • National Heart, Lung, and Blood Institute (R01HL094525, HL 49373, P01HL049373, HL-094525)
  • National Institute of Environmental Health Sciences (Z01ES102005)
  • National Center for Complementary and Integrative Health (AT27820)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
ABCA1, macrophages, lipid rafts, free cholesterol, Toll-like receptors, MyD88, TLR4, TLR9, TLR2, TLR7, lipopolysaccharide, CpG, inflammation, cholesterol efflux
MeSH terms
Animals, Cholesterol, Inflammation, Lipopolysaccharides, Macrophages, Mice, Inbred C57BL, Signal Transduction, NF-kappa B, Gene Deletion, ATP-Binding Cassette Transporters, Protein Transport, Membrane Microdomains, Toll-Like Receptors, Toll-Like Receptor 4, Toll-Like Receptor 9, Mice, Myeloid Differentiation Factor 88, ATP Binding Cassette Transporter 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.